OM50.F Observe Medical ASA
- Market cap
- EUR 9.23M
- P/E
- -
- P/B
- 3.61x
- ROE
- -162.4%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the fiscal year ending Dec 2025.
Is OM50.F undervalued?
Graham numberThe Graham number of Observe Medical ASA cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Observe Medical ASA fundamental analysis
No fundamental analysis for Observe Medical ASA yet.
Observe Medical ASA stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Observe Medical ASA
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a digital and automated urine measurement system for urine monitoring and biofilm con…
Full company profileObserve Medical ASA financial statements
Observe Medical ASA annual financial statements (NOK; K = thousand, M = million, B = billion, T = trillion)
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 24.0M | 19.5M | 27.9M | 17.2M | 18.8M |
| Gross Profit | 9.52M | 5.18M | 9.29M | 1.82M | 4.70M |
| Operating Income | -36.5M | -59.1M | -57.1M | -44.4M | -37.3M |
| EBITDA | - | -36.0M | -114M | -34.8M | -30.2M |
| Net Income | -26.3M | -50.8M | -135M | -58.7M | -48.6M |
| EPS | -8.08 | -7.14 | -5.90 | -1.79 | -0.36 |
| Balance Sheet | |||||
| Total Assets | 71.7M | 216M | 174M | 143M | 101M |
| Total Liabilities | 85.9M | 77.5M | 133M | 122M | 71.2M |
| Shareholders' Equity | -14.1M | 138M | 40.9M | 21.1M | 30.0M |
| Cash & Short-term Investments | 2.86M | 13.6M | 13.7M | 1.98M | 11.5M |
| Cash Flow | |||||
| Operating Cash Flow | -22.1M | -51.3M | -24.5M | -27.4M | -24.8M |
| Capital Expenditure | 4.89M | 4.93M | 8.02M | 1.84M | 1.14M |
| Free Cash Flow | -27.0M | -56.3M | -32.5M | -29.3M | -26.0M |
| Ratios | |||||
| ROE | - | -36.7% | -330.6% | -277.9% | -162.4% |
| ROA | -36.7% | -23.5% | -77.8% | -41.2% | -48.1% |
| Net Profit Margin | -109.5% | -260.2% | -483.5% | -340.9% | -258.6% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Observe Medical ASA dividends
Observe Medical ASA has not paid dividends in the last 5 fiscal years.
Last stock split: 1:15 on Jan 14, 2025.
Who owns Observe Medical ASA
- Insiders 58.75%
- Institutions 1.23%
- Public & others 40.02%
- Shares outstanding 136M
- Free float 30.7M
Observe Medical ASA company profile
- Company name
- Observe Medical ASA
- Ticker
- OM50.F
- ISIN
- NO0013457952
- Exchange
- Frankfurt Exchange
- Sector
- Healthcare
- Industry
- Medical Devices
- Employees
- 5
- Fiscal year end
- December
- Address
- Dronning Eufemias gate 16, Oslo, Norway, 0191
- Website
- observemedical.com
About Observe Medical ASA
Observe Medical ASA develops and commercialize medical technology products for patients, healthcare professionals, and hospitals in Europe, Asia, and the Americas. The company offers UnoMeter portfolio comprising Unometer, Safeti Plus, Unometer 500, and UnoMeter AbdoPressure products used for manual urine output measurement and for measuring intra-abdominal pressure. It also provides Sippi, a digital and automated urine measurement system for urine monitoring and biofilm control. Observe Medical ASA was founded in 2009 and is headquartered in Oslo, Norway.
Observe Medical ASA management
2- Mr. Jorgen MannChief Executive Officer
- Mr. Johan M. FagerliChief Financial Officer